Home

D. E. SHAW & CO, L.P.

CIK 1009268 · last filed 2025-03-05

D. E. SHAW & CO, L.P. is a corporate insider who has filed 17 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider sold $9.0M of IBTA on Mar 5, 2025. Across all open-market trades the lifetime net is −$1.54B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.72B across reported positions. The firm reports its address in New York, NY. 121 SEC filings were submitted jointly with DAVID E SHAW.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.72B

Companies

7

Total Filings

17

Lifetime Open-Market Net

-$1.54B

Filer Profile

Reported Address
TWO MANHATTAN WEST
375 NINTH AVENUE, 52ND FLOOR
NEW YORK, NY 10001
Phone
(212) 478-0000
State of Incorporation
DE
Formerly Known As
SHAW D E & CO L P /NY/ (1999–2006)
Related Filers
DAVID E SHAW — 121 joint filings, latest 2025-03-05
D. E. SHAW & CO, L.L.C. — 107 joint filings, latest 2025-03-05
D. E. SHAW LAMINAR PORTFOLIOS, L.L.C. — 76 joint filings, latest 2010-06-14
D. E. Shaw Oculus Portfolios, L.L.C. — 26 joint filings, latest 2018-05-17
ENDO PHARMACEUTICALS HOLDINGS INC — 11 joint filings, latest 2013-02-14
D. E. Shaw CF-SP Franklin, L.L.C. — 10 joint filings, latest 2018-05-17
D. E. Shaw Direct Capital, L.L.C. — 9 joint filings, latest 2015-05-29
DC Funding SPV 2, L.L.C. — 9 joint filings, latest 2015-05-29
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IBTA 10%+ Owner 674,729 $41.89 $28.26M -$683.5K 4 2025-03-05
JRVR Director 0 $3.56 $0 -$815.07M 2 2018-05-17
Stellus Capital Investment Corp (SCQ) Delisted 0 — — -$89.03M 1 2015-05-29
SCM 10%+ Owner 1,875,858 $7.62 $14.30M -$1.13M 3 2013-09-16
ENDO HEALTH SOLUTIONS INC. (ENDP) Delisted 10%+ Owner 11,623,014 $0.29 $3.40M -$77.11M 1 2009-03-09
OC Director 13,164,681 $123.83 $1.63B -$561.87M 2 2008-05-27
ITG 10%+ Owner 4,396,392 $10.51 $46.18M $2.31M 1 2007-11-20

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-03-05 IBTA Sell (S) −271,098 -$9.04M EDGAR
2024-10-04 IBTA Buy (P) +55,149 $3.40M EDGAR
2024-10-02 IBTA Buy (P) +40,305 $2.48M EDGAR
2024-10-01 IBTA Buy (P) +40,305 $2.48M EDGAR
2018-05-17 JRVR Sell (S) −19,783,428 -$712.20M EDGAR
2017-11-29 JRVR Sell (S) −2,700,000 -$102.87M EDGAR
2015-05-29 Stellus Capital Investment Corp (SCQ) Delisted Sell (S) −7,500,232 -$89.03M EDGAR
2013-09-16 SCM Sell (S) −6,000 -$90.0K EDGAR
2013-09-09 SCM Sell (S) −25,280 -$378.0K EDGAR
2013-08-29 SCM Sell (S) −44,756 -$665.9K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.